Affective Instability and Regular Cannabis Use During Adolescence and Subsequent Risk for Psychosis in Early Adulthood: A Longitudinal Birth Cohort Study

青少年时期的情感不稳定和规律性大麻使用与成年早期精神病风险:一项纵向出生队列研究

阅读:1

Abstract

BACKGROUND AND HYPOTHESIS: Affective instability (AffI) is associated with psychosis, and cannabis use is a known risk factor for psychosis. Previous evidence suggests that AffI may itself be a risk factor for cannabis use. This study aimed to investigate the longitudinal relationship between AffI and cannabis use during adolescence and the development of psychosis in early adulthood. STUDY DESIGN: Data from the Avon Longitudinal Study of Parents and Children were analyzed to estimate the prevalence of AffI at age 12 and cannabis use frequency at ages 13, 14, 15, 17, 20, and 22. Psychotic experiences (PEs) and psychotic disorder (PD) were measured at age 24 using the Psychosis-like Symptoms Interview. Latent class growth analysis identified cannabis use trajectories and odds ratios (OR) were calculated to assess associations between adolescent AffI, different cannabis use patterns and psychotic outcomes. Path analysis was used to examine cannabis use as a mediator between AffI and psychotic outcomes. STUDY RESULTS: Individuals with AffI were significantly more likely to develop psychotic outcomes at age 24 [PEs: OR = 4.08 (2.35–7.08); PD: OR = 4.74 (2.00–11.27)]. Regular cannabis users from ages 13–22 had an increased likelihood of developing psychotic outcomes compared with non-users [PEs: OR = 4.40 (2.79–6.92); PD: OR = 3.13 (1.25–7.88)]. Regular cannabis use partially mediated the relationship between AffI and both PEs and PD. CONCLUSIONS: Adolescents with AffI are at a higher risk of developing psychosis in early adulthood. Regular cannabis use mediates this risk, suggesting the potential benefit of targeted prevention strategies for at-risk youth.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。